BRAF V600E mutation in papillary thyroid microcarcinoma: is it a predictor for the prognosis of patients with intermediate to high recurrence risk?
Endocrine（2023）
摘要
ChiCTR2200062911.
更多查看译文
关键词
Radioiodine therapy, BRAF(V600E), Papillary thyroid microcarcinoma, Therapy response
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要